BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Singapore

WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Facility in Singapore

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced ...

March 19, 2024 | News

BioNTech Amplifies Singapore's Biopharma Innovation with BioPIPS Entry

Singapore's biopharmaceutical landscape has taken a significant leap forward with the expansion of the Biologics Pharma Innovation ...

March 18, 2024 | News

Novartis Invests $256 Million to Expand Biopharmaceutical Manufacturing in Singapore, Bolstering Asian Market Supply

Invests US$256 million to expand biopharmaceutical manufacturing facility in Singapore, addressing the soaring demand in the Asian market ...

March 15, 2024 | News

Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

Hyphens Pharma International Limited (“Hyphens Pharma”, “凯帆药剂国际有限公司”, or the “Company”, and togeth...

March 13, 2024 | News

APPIS 2024: Driving Better Health in Asia, Middle East & Africa

The 4th annual Alliance & Partnerships for Patient Innovation & Solutions (APPIS) Summit will take place on Tuesday, March 19, and Wednesday, ...

March 13, 2024 | News

Glen Godresse Charts a New Course for Menarini Asia-Pacific: A Vision of Growth Through Patient-Centric Innovation

BioPharma APAC sits down with Glen Godresse, the newly appointed Chief Executive Officer of Menarini Asia-Pacific, to discuss his strategic vision for the ...

March 13, 2024 | Interview

LogiPharma Asia is back for its 3rd edition this June 2024

This distinguished summit is uniquely positioned for global decision-makers and Asia-based supply chain leaders from world-leading pharmaceutical a...

March 06, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

March 06, 2024 | News

Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific

Menarini Asia-Pacific is thrilled to announce the appointment of Glen Godresse as the company's Chief Executive Officer, effective March 1st, 2024. Bringin...

March 01, 2024 | News

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...

February 22, 2024 | News

AffaMed's NDA for DEXTENZA Accepted by Singapore HSA for Post-Surgery Ocular Treatment

AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products&...

February 19, 2024 | News

Merck's Digital Hub in Singapore Pioneers Healthcare and Semiconductor Advancements

Merck, with over 350 years of groundbreaking scientific contributions, continues its legacy of innovation with the establishment of the Merck Digital Hub i...

February 09, 2024 | Interaction

QIAGEN Revolutionizes Diagnostic Testing with HSA Approval of QIAstat-Dx Meningitis/Encephalitis Panel

QIAGEN, a global leader in molecular diagnostics, proudly announces the approval of its QIAstat-Dx Meningitis/Encephalitis Panel by the Health Sciences Aut...

February 06, 2024 | News

Jiva.AI and Aevice Health Partner to Advance Medical AI for Asthma Prediction Using FDA-Cleared Remote Patient Monitor

The collaboration represents a synergistic blend of Jiva.ai's cutting-edge AI capabilities and Aevice Health's expertise in developing a proprietary ...

February 06, 2024 | News

Stay Connected